EXHIBIT 31.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER



I, John Olynick, certify
that:



1.   I have reviewed this
Annual Report on Form 10-K of UMED Holdings, Inc.;



2.   Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;



3.   Based on my knowledge,
the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of UMED Holdings, Inc. as of, and for, the periods presented in this
report;



4.   UMED Holdings, Inc.'s
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f)and 15d-15(f)) for UMED Holdings, Inc. and have:



|(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to UMED Holdings, Inc. is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(c) | Evaluated the effectiveness of UMED
Holdings, Inc.'s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(d) | Disclosed
    in this report any change in UMED Holdings, Inc.'s internal control over financial reporting that occurred during UMED Holdings,
    Inc.'s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, UMED Holdings,
    Inc.'s internal control over financial reporting; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



5.   UMED Holdings, Inc.'s
other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to UMED Holdings, Inc.'s auditors and the audit committee of UMED Holdings, Inc.'s board of directors (or persons performing the
equivalent functions):



|(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect UMED H9oldings, Inc.'s ability to record, process, summarize and report financial information; and
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in UMED Holdings, Inc.'s internal control over financial reporting.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date: July 19, 2018



/s/ John Olynick

John Olynick

| | President | 
| | --------- |